Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Contemporary Oncology (Poznan, Poland)|November 29, 2017
Osimertinib - effective treatment of NSCLC with activating EGFR mutations after progression on EGFR tyrosine kinase inhibitorsMarcin Skrzypski, Amelia Szymanowska-Narloch, Rafał Dziadziuszko
Frontiers in Medicine|August 15, 2022
IPF Respiratory Symptoms Management - Current EvidencePiotr Janowiak, Amelia Szymanowska-Narloch, Alicja Siemińska
Pneumonologia I Alergologia Polska|November 6, 2009
[Smoking and lung cancer]Ewa Jassem, Amelia Szymanowska, Alicja Siemińska, et al.
Advances in Respiratory Medicine|January 24, 2020
Atypical manifestations of granulomatosis with polyangiitis: the diagnostic challenge for pulmonologistsAmelia Szymanowska-Narloch, Dariusz Gawryluk, Katarzyna Błasińska-Przerwa, et al.
Polski Merkuriusz Lekarski : Organ Polskiego Towarzystwa Lekarskiego|April 30, 2005
[Thymectomy in myasthenia gravis]Witold Rzyman, Jan Skokowski, Tomasz Marjański, et al.
The Journal of Thoracic and Cardiovascular Surgery|September 23, 2003
The influence of blood transfusion on survival in operated non-small cell lung cancer patientsWitold Rzyman, Rafal Dziadziuszko, Jan Skokowski, et al.
Lung Cancer (Amsterdam, Netherlands)|February 28, 2006
Increased risk of non-small cell lung cancer and frequency of somatic TP53 gene mutations in Pro72 carriers of TP53 Arg72Pro polymorphismAmelia Szymanowska, Ewa Jassem, Rafał Dziadziuszko, et al.
Pneumonologia I Alergologia Polska|June 2, 2007
[Quality of life of patients with asthma which has been well and poorly controlled]Marta Chełmińska, Lidia Werachowska, Marek Niedoszytko, et al.
Pneumonologia I Alergologia Polska|September 23, 2006
[Analysis of prognostic value of TP53 gene mutations in non-small cell lung cancer]Amelia Szymanowska, Ewa Jassem, Rafał Dziadziuszko, et al.
Pageof 2